Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-12-15
著者
-
AKIYAMA Hideki
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
SAKAMAKI Hisashi
Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital
-
Katayama Y
Division Of Hematology Saitama Medical Center Jichi Medical University
-
TAGUCHI Jun
Department of Hematology and Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Univer
-
TAWARA Masayuki
Nagasaki CML Study Group
-
OKAMOTO Shinichiro
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
KANAMORI Heiwa
Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of
-
KANDA Yoshinobu
Department of Hematology and Oncology, Graduate School of Medicine, University of Tokyo
-
MARUTA Atsuo
Department of Hematology, Kanagawa Cancer Center
-
MORI Takehiko
Division of Hematology, Department of Medicine, Keio University School of Medicine
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Matsushima Takafumi
Department Of Hematology St. Marianna University School Of Medicine
-
Tsurusawa Masahito
Department Of Pediatrics Ibaraki Children's Hospital
-
FUJISAWA Shin
Yokohama City University Medical Center
-
Sakamaki H
Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Sakamaki Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Hiraoka Sakamaki
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Tanaka Masatsugu
Department Of Hematology Kanagawa Cancer Center
-
Okamoto S
Division Of Hematology Department Of Medicine Keio University School Of Medicine
-
Okamoto Shinichiro
慶応義塾大学 医学部内科学血液研究室
-
Tanimoto M
Blood Transfusion Division Department Of Internal Medicine Ii Okayama University Graduate School Of
-
Tanimoto Mitsune
Okayama Univ. Hospital Okayama Jpn
-
Okamoto Shin-ichiro
国立がんセンター中央病院 血液内科
-
Takahashi Masatomo
St. Marianna Univ. School Of Medicine Kawasaki Jpn
-
Takeuchi Jin
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Sakura Tohru
群馬大学 医学系研究科生体統御内科学
-
Sakura T
Department Of Medicine Saiseikai Maebashi Hospital
-
Murata Takashi
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Matsushima Takafumi
群馬大学 医学系研究科生体統御内科学
-
Tomonaga Masao
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Taniwaki M
Celgene Kk
-
Tanimoto Mitsune
Kobe Univ. Graduate School Of Medicine Kobe Jpn
-
Kaji Yoshikazu
Medicine And Biosystemic Science Kyushu University Graduate School Of Medical Sciences
-
Saito H
Nagoya Central Hospital
-
YOKOTA Akira
Department of Neurosurgery, School of Medicine, University of Occupational and Environmental Health
-
Soda Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Soda Hisashi
Department Of Internal Medicine Isahaya Insurance General Hospital
-
Suzuki Hisamitsu
国立療養所中部病院長寿医療研究センター
-
MAEDA Takahiro
Unit of General Medicine
-
KISHI Kenji
Division of Pathogenesis and Disease Control, Department of Infectious Diseases, Oita University Fac
-
Mori Takehiko
Division Of Hematology Department Of Medicine Keio University School Of Medicine
-
Kanamori Heiwa
Department Of Hematology Kanagawa Cancer Center
-
Kanamori Heiwa
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
FUJIMAKI Katsumichi
Department of Internal Medicine and Clinical Immunology, Yokohama City University, Graduate School o
-
KIDA Aiko
Hematology Division, Tokyo Metropolitan Komagome Hospital
-
KAWAI Nobutaka
Division of Hematology, Department of Internal Medicine, Saitama Medical School
-
FUJISAWA Shin
Department of Hematology, Yokohama City University Medical Center
-
SAKURA Tohru
Division of Hematology, Saiseikai Maebashi Hospital
-
Okamoto Shin-ichiro
Division Of Hematology Department Of Medicine Keio University School Of Medicine
-
Sakamaki H
Division Of Hematology Tokyo Metropolitan Komagome Hospital
-
Sakamaki Hisashi
Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University
-
Akiyama Hideki
Hematology Division Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Akiyama Hideki
Hematology Division Tokyo Metropolitan Komagome Hospital
-
Okamoto Shin-ichiro
Department Of Medicine Keio University School Of Medicine
-
Maruta Atsuo
Department Of Hematology Kanagawa Cancer Center
-
Maruta A
Kanagawa Cancer Center Yokohama City Jpn
-
Katayama Yoshio
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Kanda Yoshinobu
Department Of Cell Therapy And Transplantation Medicine University Of Tokyo Hospital
-
Saito H
Nagoya National Hospital Nagoya Jpn
-
Tanimoto Mitsune
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Sakamaki Hisashi
Tokyo Metropolitan Komagome Hospital Tokyo Jpn
-
Sakamaki H
Tokyo Metropolitan Komagome Hospital Tokyo Jpn
-
Tsuchida M
Department Of Pediatrics Ibaraki Children's Hospital
-
Okamoto Shinichiro
Division Of Hematology Department Of Internal Medicane Keio University School Of Medicine
-
Okamoto Shinichiro
Division Of Hematology/infectious Disease/rheumatology School Of Medicine Keio University
-
Okamoto Shinichiro
Department Of Hematology Keio University School Of Medicine
-
Motoji Toshiko
Tokyo Women's Medical University
-
Yokota Akira
Department Of Neurosurgery School Of Medicine University Of Occupational And Environmental Health
-
Katayama Yoshio
Department Of Hematology And Oncology Graduate School Of Medicine University Of Tokyo
-
Mori Takehiko
Keio Univ. School Of Medicine Tokyo Jpn
-
Tomonaga Masao
Atomic Bomb Disease Institute Nagasaki Univ. Graduate School Of Biomedical Sciences.
-
Saito Hidehiko
Nagoya Central Hospital Nagoya Jpn
-
Kida Aiko
Hematology Division Tokyo Metropolitan Komagome Hospital
-
Kishi Kenji
Shibata Prefectural Hospital Niigata Jpn
-
Kishi Kenji
Division Of Internal Medicine Shibata Prefectural Hospital
-
Okamoto Susumu
Department Of Internal Medicine Division Of Gastroenterology And Hepatology Keio University School O
-
Kawai Nobutaka
Division Of Hematology Department Of Internal Medicine Saitama Medical School
-
Taguchi Jun
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Taguchi Jun
Department Of Hematology Kanagawa Cancer Center
-
Yakushiji Kazuaki
Division Of Hematology Department Of Medicine Kurume University School Of Medicine
-
Kanda Yoshinobu
Department Of Cell Therapy And Transplantation Medicine University Of Tokyo
-
Suzuki Hideyoshi
Division Of Hematology Tokyo Metropolitan Komagome Hospital
-
Shishido Hideo
Third Department Of Internal Medicine Dokkyo University School Of Medicine
-
Sakamaki Hisashi
Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital
-
Fujimaki Katsumichi
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Fujisawa Shin
Department Of Hematology Yokohama City University Medical Center
-
Sakura Tohru
Division Of Hematology Saiseikai Maebashi Hospital
-
Kuwabara Hideyuki
Department Of Hematology Kanagawa Cancer Center
-
Kashiwagi Yoichiro
Japan Adult Leukemia Study Group Hamamatsu Jpn
-
Yokota Akira
Department Of Internal Medicine Chiba Aoba Municipal Hospital
-
Takabayashi Maki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Kaji Yoshikazu
Division Of Hematology Saitama Medical Center Jichi Medical University
-
Fujimaki Katsumichi
Department Of Hematology/ Immunology Fujisawa City Hospital
-
Akiyama Hideki
Hematology Division, Tokyo Metropolitan Komagome Hospital
-
TAGUCHI Jun
Department of Chemistry and Materials Science Tokyo Institute of Technology
-
FUJIMAKI Katsumichi
Department of Hematology and Immunology, Fujisawa City Hospital
関連論文
- Serial monitoring of T315I BCR-ABL mutation by Invader assay combined with RT-PCR
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Use of Octreotide in the Management of Severe Duodenal Bleeding after Unrelated-Donor Bone Marrow Transplantation
- Rapidly Progressive Epstein-Barr Virus-associated Lymphoproliferative Disorder Unpredictable by Weekly Viral Load Monitoring
- 点欠陥の自己組織化的挙動を利用した微細構造形成法
- Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
- Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Allogeneic Peripheral Blood Stem Cell Transplantation in 23 Adult Patients With Hematologic Malignancies: A Single-Center Experience
- Granulocyte Colony-Stimulating Factor and Lineage-Independent Modulation of VLA-4 Expression on Circulating CD34^+ Cells
- Replating potential of colony-forming units of granulocytes/macrophages (CFE-GM) expanded ex vivo by stem cell factor, interleukin (IL)-3, IL-6, granulocyte colony-stimulating factor, erythropoietin with or without thrombopoietin
- Trisomy 12 and t(14;18) in B-cell chronic lymphocytic leukemia
- G-CSF-induced mobilization of peripheral blood stem cells for allografting: comparative study of daily single versus divided dose of G-CSF
- Androgen therapy in combination with granulocyte colony-stimulating factor and erythropoietin in a patient with refractory anemia
- Predominant Infiltration of Monocytes in Chronic Graft-Versus-Host Disease
- Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Geographical Study on the Frequency of Epilation among Atomic Bomb Survivors in Nagasaki
- Correlation between Acute Radiation Injuries and Hematological Parameters in Atomic Bomb Survivors
- Mental health conditions among atomic bomb survivors in Nagasaki
- Rapid isolation of viral integration site reveals frequent integration of HTLV-1 into expressed loci
- Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
- Multiple extra-articular synovial cysts complicated with rheumatoid arthritis
- Systemic sclerosis and pseudomesotheliomatous adenocarcinoma of the lung
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Phase II and pharmacokinetic study of thalidomide in Japanese patients with relapsed/refractory multiple myeloma
- Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
- Aplastic Anemia
- 3 Geographic Effects on Cancer Mortality in Nagasaki A-Bomb Survivors(Atomic bomb effects, Abstracts of the 46th Annual Meeting of the Japan Radiation Research Society)
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Leukemic infiltration of the lung following allogeneic hematopoietic stem cell transplantation
- Mikulicz's disease with severe thrombocytopenia following autologous stem cell transplantation in a multiple myeloma patient
- Acquired Storage-Pool Disorders Occurring Late After Allogeneic Bone Marrow Transplantation: Partial Activation of Platelets in Asymptomatic Patients
- Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
- Asymptomatic Patients with Acute Leukemias and Malignant Lymphomas Found in Ningen Dock
- Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
- Emergence of chronic myelogenous leukemia during treatment for essential thrombocythemia
- Cyclin-dependent kinase inhibitor SU9516 enhances sensitivity to methotrexate in human T-cell leukemia Jurkat cells
- Double High-dose Chemotherapy Supported by Autologous Transplantation of Peripheral Blood Stem Cells for Treatment of an Elderly Patient with Small-Cell Lung Cancer
- Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
- A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease
- Outcome of Involved-Field Radiotherapy for Stage 1 Follicular Lymphoma
- Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
- Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation
- Frequent Exacerbation of Pulmonary Nocardiosis during Maintenance Antibiotic Therapies in a Hematopoietic Stem Cell Transplant Recipient
- Immune-Mediated Myelopathy following Allogeneic Stem Cell Transplantation
- Granulocyte Colony-Stimulating Factor-Primed Donor Lymphocyte Infusion after Salvage Chemotherapy for Treatment of Relapsed Acute Leukemia after Allogeneic Stem Cell Transplantation
- Cytogenetic Abnormalities without Evidence of Relapse after Treatment with Imatinib and Stem Cell Transplantation in a Patient with Ph-Positive ALL
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Serum HO-1 is useful to make differential diagnosis of secondary hemophagocytic syndrome from other similar hematological conditions
- Autoimmune hemolytic anemia in allergic granulomatous angitis (Churg-Strauss syndrome)
- Expression of heme oxygenase-1 in human leukemic cells and its regulation by transcriptional repressor Bach1
- Cerebral venous sinus thrombosis after allogeneic stem cell transplantation
- Clinical Significance of Fragmented Red Cells after Allogeneic Bone Marrow Transplantation
- Durable Remission by Sobuzoxane in an HIV-Seronegative Patient with Human Herpesvirus 8-Negative Primary Effusion Lymphoma
- A case of systemic lupus erythematosus complicated with pneumatosis cystoides intestinalis
- Use of musculoskeletal ultrasound in Japan : a survey of practicing rheumatologists
- Quantification of Circulating Varicella-Zoster Virus DNA for Follow-up in a Case of Visceral Varicella-Zoster Infection Ameliorated with Intravenous Acyclovir
- Hepatitis B Virus Reactivation in a Patient With Chronic GVHD After Allogeneic Peripheral Blood Stem Cell Transplantation
- Imatinib Mesylate (Gleevec) in the Treatment of 2 Patients with Philadelphia-Positive ALL Relapsing after Allogeneic Stem Cell Transplantation
- Void Formation and Structure Change Induced by Heavy Ion Irradiation in GaSb and InSb
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells
- Erythrocytosis caused by erythropoietin-producing thymic carcinoma
- Low-Dose Antithymocyte Globulin for Treatment of Steroid-Pulse-Resistant Acute Graft-versus-Host Disease
- Effect of Additional Chromosomal Abnormalities in Acute Promyelocytic Leukemia Treated With All-trans-Retinoic Acid: A Report of 17 Patients
- Primary carcinoid of the testis associated with carcinoid syndrome
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Formation of Defect Structure on Ge Surface by Ion Irradiation at Controlled Substrate Temperature
- Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
- Contrast-enhanced endoscopic ultrasonography (CE-EUS) findings in adrenal metastasis from renal cell carcinoma
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- Detection of HTLV-1 by means of HBZ gene in situ hybridization in formalin-fixed and paraffin-embedded tissues
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- ABO blood group alleles and the risk of pancreatic cancer in a Japanese population
- Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Ocular palsy associated with aggressive NK-cell leukemia
- Association between insulin-like growth factor-1 polymorphisms and stomach cancer risk in a Japanese population
- M2 Macrophage/Microglial Cells Induce Activation of Stat3 in Primary Central Nervous System Lymphoma
- Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low-and low-intermediate risk, aggressive non-Hodgkin's lymphoma : final results of the Japan Clinical Oncology Group Study, JCOG95